Printer Friendly

CELOX DELIVERS FIRST SHIPMENT TO JAPAN

 MINNEAPOLIS, March 2 /PRNewswire/ -- Celox Corporation (NASDAQ: CELX) has made its first shipment of proprietary cell biology products to Funakoshi Co., Ltd., of Tokyo. Last month, Celox announced that it had entered into an exclusive, three-year sales and distribution agreement with Funakoshi.
 Funakoshi will distribute Celox's complete line of cell biology products to biotechnology, medical and pharmaceutical companies, and for use in academic research throughout Japan.
 "We are excited to have begun this new partnership with this major distributor in Japan," said Milo R. Polovina, Celox's president and CEO. "This is yet another important step in extending Celox's products globally."
 Similar agreements have been recently executed, including one with TechGen International to represent Celox's products in Europe, and Intermountain Scientific Corporation, which has commenced distribution for Celox in 14 western states.
 In a separate announcement, Celox accepted the resignation of board member, H. Clark Adams, vice president, business development and strategic planning at Pharmacia Deltec, Inc.
 Celox Corporation is a biotechnology company that researches, develops, manufactures and markets cell biology products used in the growth of cells derived from humans and other species. These specialized products are used in researching AIDS, cancer and cardiovascular disease.
 -0- 3/2/93
 /CONTACT: Milo R. Polovina, president/CEO of Celox Corporation, 612-933-2616; or Gail Shore of Shore to Shore Communications, 612-925-6102, for Celox/
 (CELX)


CO: Celox Corporation ST: Minnesota IN: MTC SU:

DS -- MN005 -- 8004 03/02/93 11:07 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 2, 1993
Words:238
Previous Article:PIPER CAPITAL ANNOUNCES FINANCIAL POSITION FOR CLOSED-END FUNDS
Next Article:ERICSSON CHOOSES LTX FOR NEW GENERATION DIGITAL TEST SYSTEM
Topics:


Related Articles
CELOX ANNOUNCES PUBLIC OFFERING
CELOX SIGNS WESTERN STATES DISTRIBUTION PACT
CELOX GRANTS DISTRIBUTION RIGHTS IN JAPAN
CELOX FILES WITH FDA FOR NEW REGISTRATION STATUS TO BECOME A MEDICAL DEVICE COMPANY -- WILL ALLOW COMPANY TO ENTER NEW BIOTECH MARKETS
CELOX BEGINS DISTRIBUTION AGREEMENT IN TAIWAN
CELOX ANNOUNCES ADDITION TO BOARD OF DIRECTORS
CELOX CORPORATION ANNOUNCES THIRD QUARTER RESULTS
CELOX CORPORATION ANNOUNCES COLLABORATION WITH MEMORIAL BLOOD CENTERS OF MINNESOTA
CELOX CORPORATION ANNOUNCES NAME CHANGE AND ADDITIONAL ACTIVITIES AT ANNUAL MEETING
Celox Laboratories, Inc. Announces Receipt of Notice of Allowance for Patent on ViaStem

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters